Croda to supply innovative delivery system to Pfizer for COVID-19 vaccine

Croda International recently entered into an agreement with Pfizer to supply novel excipients used in the manufacture of a COVID-19 vaccine candidate.

The contract with Pfizer runs for five years and awards Croda an initial supply agreement for four component excipients used in the production of the vaccine candidate for the first three years of the contract. Demand remains subject to relevant approvals.

Croda’s recently acquired subsidiary, Avanti Polar Lipids specialises in the development and production of high-purity lipids, to produce research and clinical trial quantities of excipients in order to stabilise formulations and enable delivery into the body by parenteral mechanism for drug and vaccine applications.

Image by Alexandra_Koch from Pixabay
Croda will supply Pfizer with novel excipients used in the manufacture of a COVID-19 vaccine candidate

A leader in drug delivery systems

The existing healthcare business of the speciality chemical company has a 20-year track record in developing IP-rich, innovative technologies for drug delivery systems for the pharmaceutical industry. Croda has been working with Avanti, prior to and since the acquisition, to refine the complex processes involved in achieving the volumes of high-purity excipients required by its pharmaceutical customers. Croda has reprioritised investment, resources and other projects across the group over the last few months to focus on the delivery of this project.

Commenting on the new contract, Steve Foots, Croda CEO said: “I’m very proud of Croda’s involvement in the battle to fight the most significant pandemic that we have seen in a generation. The application of our innovative capabilities is testament to the strong progress we have made to create industry-leading drug delivery systems, focused on developing speciality excipients and adjuvants to improve the effectiveness and stability of complex drug actives and vaccines. It is another example of why our purpose – smart science to improve lives – sits at the heart of our strategy and will continue to drive our priorities and ambitions in the years ahead.”

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. The person responsible for making this announcement is David Bishop, director of investor relations.



Latest


04 May 2021
Seppic revisits beauty rituals with texturising ingredients

Through its Breathtaking Rituals collection, Seppic puts science at the service of beauty to discover the textures of tomorrow. For…

Seppic revisits beauty rituals with texturising ingredients

Through its Breathtaking Rituals collection, Seppic puts science at the service of beauty to discover the textures of tomorrow. For its 2021 Texture Bar, Seppic invites beauty brands and formulators to travel through time. Influenced by ancestral, healing and local Japanese beauty rituals, the breathtaking rituals concept is based on…

30 Apr 2021
Omya to host online oral care symposium

Omya is hosting a third international summit addressing latest oral care innovations and developments, along with online presentations and opportunities…

Omya to host online oral care symposium

Omya is hosting a third international summit addressing latest oral care innovations and developments, along with online presentations and opportunities for discussion. The virtual event takes place on 8 and 9 June 2021. Registration is free of charge and participants will be able to learn more about oral wellness and…

30 Apr 2021
Insilico Advisor improves the efficiency of biologics manufacturing

Insilico Biotechnology AG has released a new product, the Insilico Advisor to improve efficiency of biologics manufacturing. The manufacturing of…

Insilico Advisor improves the efficiency of biologics manufacturing

Insilico Biotechnology AG has released a new product, the Insilico Advisor to improve efficiency of biologics manufacturing. The manufacturing of biologics with consistent quality is challenging. Since the quality of biologics is impacted greatly by the cell culture process, the robustness of this process must be maintained in the face…

29 Apr 2021
Dow launches a Virtual Experience Centre to inspire beauty innovations

The new Virtual Experience Centre (VEC) by Dow offers beauty brands an immersive 3D platform to dive into the future…

Dow launches a Virtual Experience Centre to inspire beauty innovations

The new Virtual Experience Centre (VEC) by Dow offers beauty brands an immersive 3D platform to dive into the future of beauty care. Within the platform, visitors can discover the latest innovations, marketing trends and regulatory information, and interact with Dow’s scientific and regulatory experts. From the comfort of their…


Top stories


30 Nov 2017
Rooibos could reduce risk of “Type 3” diabetes – a precursor to Alzheimer’s

Researchers at Warren Alpert Medical School at Brown University in the US found a link between a relatively new form…

Rooibos could reduce risk of “Type 3” diabetes – a precursor to Alzheimer’s

Researchers at Warren Alpert Medical School at Brown University in the US found a link between a relatively new form of diabetes, known as “type 3” diabetes and Alzheimer’s disease.

25 Jun 2020
How to ensure business agility in a pandemic

BY: Neil Birch, CEO at Novus Holdings Business agility is the capability of a business to respond quickly to a…

How to ensure business agility in a pandemic

BY: Neil Birch, CEO at Novus Holdings Business agility is the capability of a business to respond quickly to a changing environment, whether it be internal or external. Qualities of agile businesses include being adaptive, flexible and creative in your response to change without losing momentum (remaining productive) or vision.…

01 May 2020
Fibertex manufactures critical components for COVID-19 PPE

Fibertex SA, part of the global Fibertex Nonwovens group, has developed versatile high-performance components for protective facemasks and respirators. “Fibertex,…

Fibertex manufactures critical components for COVID-19 PPE

Fibertex SA, part of the global Fibertex Nonwovens group, has developed versatile high-performance components for protective facemasks and respirators. “Fibertex, which continuously invests in technological advancements to meet requirements in diverse industries – has increased production capacity of materials so desperately needed during the global COVID-19 pandemic,” explains Rosa Naidoo,…

23 Apr 2020
Are you South Africa’s best female entrepreneur?

Entries are now open for the Santam Women of the Future Awards 2020 in association with Fairlady and True Love.…

Are you South Africa’s best female entrepreneur?

Entries are now open for the Santam Women of the Future Awards 2020 in association with Fairlady and True Love. Santam, Fairlady and, for the first time this year, Truelove Magazine, have partnered up in the search to find the best female entrepreneurs in the country. Best women entrepreneurs If…


Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za